CMPS included in ETFs
Dates are bounded by retained official portfolio snapshots; baseline presence is never presented as an original addition date.
Current ETFs holding CMPS
10 latest ETF portfolios currently report this security. This page shows rows 1–10 of 10.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| PSIL | AdvisorShares Psychedelics ETF | 6.738506% | Present before retained history; addition date unavailable | 2026-03-31 |
| ARKG | ARK Genomic Revolution ETF | 2.430967% | 2022-10-31 | 2026-04-30 |
| SURI | Simplify Propel Opportunities ETF | 1.268282% | 2025-09-30 | 2026-03-31 |
| BBC | Virtus Biotech Clinical Trials Etf | 0.993738% | 2021-07-30 | 2026-04-30 |
| BRW | Saba Capital Income & Opportunities Fund | 0.140639% | 2026-04-30 | 2026-04-30 |
| GWX | State Street(R) SPDR(R) S&P(R) International Small Cap ETF | 0.054817% | 2026-03-31 | 2026-03-31 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.047909% | 2026-02-28 | 2026-02-28 |
| IBB | iShares Biotechnology ETF | 0.041676% | 2026-03-31 | 2026-03-31 |
| RVT | ROYCE SMALL-CAP TRUST, INC. | 0.032972% | 2026-03-31 | 2026-03-31 |
| BIB | ProShares Ultra Nasdaq Biotechnology | 0.032736% | 2026-02-28 | 2026-02-28 |